Alere Determine Combo HIV 1/2 Ag/Ab rapid test for HIV
Alere Australia has gained approval for the marketing in Australia of the Alere Determine Combo HIV 1/2 Ag/Ab rapid test for HIV. This marks the first approval for an innovative HIV assay to be included on the Australian Register of Therapeutic Goods (ARTG) for use in a point-of-care situation.
Marketing approval required lengthy scrutiny by the TGA of the scientific and clinical evidence supporting the test, including its accuracy when performed in near patient situations by healthcare professionals other than pathology laboratory scientists.
The point-of-care test offers significant benefits to patients and to healthcare workers in terms of convenience and rapid management of immediate clinical issues. It brings HIV testing technology right to the patient’s bedside.
Phone: 07 3363 7100
Beckman Coulter Life Sciences Valita Aggregation Pure assay
Beckman Coulter Life Sciences' Valita Aggregation Pure assay is a plate-based, 96-well...
BioStatus DRAQ9 Far-Red Fluorescent Live-Cell Tracking Dye
BioStatus's DRAQ9 is a novel far-red fluorescent dye that labels membranous structures in the...
Invent Biotechnologies Minute Plasma Membrane Protein Isolation and Cell Fractionation Kit
Invent Technologies Minute kits are next-generation products for plasma membrane (PM) isolation...
